Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
An update from Silk Road Medical ( (SILK) ) is now available.
Silk Road has fully repaid its debt to Oxford Finance and terminated related obligations following the completion of a merger on September 17, 2024. This included a 1% prepayment fee as the loans were settled before the May 1, 2027 maturity date. Additionally, Silk Road paid a $367,500 success fee to Stifel Bank due to the merger, which constituted a Liquidity Event as per their agreement. Following the merger, Silk Road’s common stock was delisted from Nasdaq, and all associated registration and reporting obligations were set to be terminated. Consequently, all shares of common stock were converted into the right to receive the merger consideration, ceasing existing stockholder rights except for receiving this consideration.
For an in-depth examination of SILK stock, go to TipRanks’ Stock Analysis page.
